Manekya, Anika, and Bjoern participated in the CVB2025 Meeting in Ann Arbor

Manekya, Anika, and Bjoern recently participated in the CVB2025 Meeting in Ann Arbor, MI. Manekya presented a poster on the therapeutic potential of mPGES-1 and 5-LOX inhibition to repair blood-brain barrier dysfunction in epilepsy. Anika was an invited speaker and delivered a talk on blood-brain barrier disruption in Alzheimer’s disease. Bjoern gave a short presentation on targeting endocannabinoid signaling for blood-brain barrier repair and seizure control in epilepsy.

Recent Posts

Dr. Britta Engelhardt was invited for a special summer seminar

A special summer seminar was co-organized by Anika, Bjoern, and Dr Ann Stowe, featuring guest speaker Dr. Britta Engelhardt, Director of the Theodor Kocher Institute at the University of Bern, Switzerland. Dr. Engelhardt is a globally recognized leader in immunobiology and an expert on the blood-brain barrier. She presented a

Read More »

Bjoern selected as Patrick DeLuca Endowed Professor of Pharmaceutical Technology

Bjoern has been selected as the Patrick DeLuca Endowed Professor of Pharmaceutical Technology, honoring his outstanding record of service, research excellence, and leadership within the College of Pharmacy. This prestigious appointment recognizes Bjoern’s significant contributions to pharmaceutical innovation and his dedication to advancing the field. Congratulations on this well-deserved honor, Bjoern!

Read More »